Cite
Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer.
MLA
Aoyama, Ryuhei, et al. “Long-Term Results of a Phase 2 Study of Neoadjuvant Chemotherapy with Molecularly Targeted Agents for Locally Advanced Rectal Cancer.” International Journal of Clinical Oncology, vol. 28, no. 3, Mar. 2023, pp. 392–99. EBSCOhost, https://doi.org/10.1007/s10147-023-02291-4.
APA
Aoyama, R., Hida, K., Hasegawa, S., Yamaguchi, T., Manaka, D., Kato, S., Yamada, M., Yamanokuchi, S., Kyogoku, T., Kanazawa, A., Kawada, K., Sakamoto, T., Goto, S., Sakai, Y., & Obama, K. (2023). Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer. International Journal of Clinical Oncology, 28(3), 392–399. https://doi.org/10.1007/s10147-023-02291-4
Chicago
Aoyama, Ryuhei, Koya Hida, Suguru Hasegawa, Takashi Yamaguchi, Dai Manaka, Shigeru Kato, Masahiro Yamada, et al. 2023. “Long-Term Results of a Phase 2 Study of Neoadjuvant Chemotherapy with Molecularly Targeted Agents for Locally Advanced Rectal Cancer.” International Journal of Clinical Oncology 28 (3): 392–99. doi:10.1007/s10147-023-02291-4.